Qmedtrix Systems, Inc. – Trademark Portfolio

Entity Type: 03

Qmedtrix Systems, Inc. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 11 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. The owner is based in Portland, OR.

12th Floor

700 NE Multnomah Street

Portland, OR 97232

14 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Qmedtrix Systems, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (11 filings)

Advertising; business management; business administration; office functions

9
Computers & Electronics (6 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

45
Legal & Security Services (2 filings)

Legal services; security services for the protection of property and individuals

Frequently Asked Questions

How many trademarks does Qmedtrix Systems, Inc. have?

Qmedtrix Systems, Inc. has 14 U.S. trademarks filed with the USPTO.

What trademark classes does Qmedtrix Systems, Inc. file in?

Qmedtrix Systems, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). Class 35 covers advertising; business management; business administration; office functions.

What is Qmedtrix Systems, Inc.'s trademark registration success rate?

Qmedtrix Systems, Inc. has a 0% trademark registration rate, with 0 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.